[Google's Isomorphic Labs to Raise $2 Billion in New Funding] According to a report by Golden Finance on May 9, sources revealed that Isomorphic Labs, an AI drug discovery company spun off from Google's DeepMind, is in deep discussions to raise over $2 billion in a new round of financing. The sources stated that Thrive Capital, the venture capital firm that led Isomorphic Labs' first round of financing last year, will spearhead the new round. One of the sources mentioned that Alphabet is also involved, but the round of financing has not yet concluded.